ADE000968
1H-pyrrolo[3,2-b]pyridine
AldrichCPR
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Formule empirique (notation de Hill):
C7H6N2
Numéro CAS:
Poids moléculaire :
118.14
Numéro MDL:
Code UNSPSC :
12352200
ID de substance PubChem :
Produits recommandés
![1H-pyrrolo[3,2-c]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/291/250/879d6f32-75bf-4a4a-a366-18cbd62dcc37/640/879d6f32-75bf-4a4a-a366-18cbd62dcc37.png)
![1H-Pyrrolo[2,3-c]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/332/393/b23058ac-c477-42b5-9890-dc5c2af5cec7/640/b23058ac-c477-42b5-9890-dc5c2af5cec7.png)
![4-Iodo-1H-pyrrolo[2,3-b]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/296/181/125fbe1d-3d80-4d64-b93a-f92f6ce766ba/640/125fbe1d-3d80-4d64-b93a-f92f6ce766ba.png)
![1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/238/208/7cc66a5b-8290-425e-8cbf-2364ca9114e9/640/7cc66a5b-8290-425e-8cbf-2364ca9114e9.png)
![1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/505/605/6b5b15eb-77f0-40a2-bd37-fff8f3526e8e/640/6b5b15eb-77f0-40a2-bd37-fff8f3526e8e.png)
Forme
solid
Chaîne SMILES
c1cnc2cc[nH]c2c1
InChI
1S/C7H6N2/c1-2-6-7(8-4-1)3-5-9-6/h1-5,9H
Clé InChI
XWIYUCRMWCHYJR-UHFFFAOYSA-N
Autres remarques
Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.
NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
Informations légales
Product of Adesis
Mention d'avertissement
Danger
Mentions de danger
Conseils de prudence
Classification des risques
Acute Tox. 4 Oral - Eye Dam. 1
Code de la classe de stockage
11 - Combustible Solids
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Faites votre choix parmi les versions les plus récentes :
Certificats d'analyse (COA)
Lot/Batch Number
Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.
Si vous avez besoin d'assistance, veuillez contacter Service Clients
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Taleen S Der-Ghazarian et al.
ACS chemical neuroscience, 10(7), 3271-3283 (2019-05-03)
5-HT1B receptors (5-HT1BRs) modulate psychostimulant reward and incentive motivation in rodents. Here we investigated the effects of the 5-HT1BR agonist CP94253 (10 mg/kg, IP) on the acquisition and expression of methamphetamine (Meth) conditioned place preference (CPP) in C57BL/6 male mice.
Jessica Karlsson et al.
PloS one, 10(11), e0142711-e0142711 (2015-11-14)
Combined fatty acid amide hydrolase (FAAH) and cyclooxygenase (COX) inhibition is a promising approach for pain-relief. The Flu-AM1 and Ibu-AM5 derivatives of flurbiprofen and ibuprofen retain similar COX-inhibitory properties and are more potent inhibitors of FAAH than the parent compounds.
Bruno Aleksander Martek et al.
Drug testing and analysis, 11(4), 617-625 (2019-02-08)
The high frequency of the synthetic cannabinoid receptor agonists (SCRAs) emergence renders this group of new psychoactive compounds particularly demanding in terms of detection, identification, and responding. Without the available reference material, one of the specific problems is differentiation and
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique